サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1429528

ラテラルフローイムノアッセイ（LFIA）ベース迅速検査の世界市場レポート 2024

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
ラテラルフローイムノアッセイ（LFIA）ベース迅速検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ラテラルフローイムノアッセイ（LFIA）ベース迅速検査の市場規模は、今後数年間で若干の減少が見込まれると予想されます。 2028年には-1.6%の年間複合成長率（CAGR）で77億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、ヘルスケアアクセスの増加、COVID-19感染症パンデミックの影響、高齢化人口の増加、在宅側方流動アッセイ装置に対する需要の増大、アクセシビリティの向上、および規制当局の承認が増加。予測期間における注目すべき動向には、複数または反復的なLFIAベースの迅速テストと結果の保存/通信のための技術の進歩が含まれます。また、新製品または改良された製品を導入するためのパートナーシップやコラボレーションの形成、患者が自宅で自己管理および健康管理を行うための在宅検査キットの開発、疾病スクリーニングのための人工知能ベースの検査への投資にも焦点を当てています。そして、患者が手頃な価格でアクセスできるようにするために、低コストの検査キットを作成することが不可欠です。

ラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場は、在宅医療環境におけるポイントオブケア検査の需要によって成長すると予想されています。ポイントオブケア検査は現場での迅速な診断と治療に不可欠であり、LFIAはそのスピード、精度、シンプルさ、費用対効果の高さから広く使用されています。最近のCOVID-19の流行は、Acro Biotech COVID-19 Rapid POC CE-IVDや、COVID-19に対するラテックス強化側方流動免疫測定法（LFIA）を採用したOZOのバリエーションなどの製品に見られるように、迅速なスクリーニングと監視のためのLFIAデバイスの重要性を強調しています。 19回のテスト。その結果、在宅医療現場におけるポイントオブケア検査の必要性により、市場は成長すると予想されます。

ラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場は、慢性疾患の有病率の増加によって成長が見込まれています。これらの長期にわたる健康状態には、早期発見、ポイントオブケア検査、定期的なモニタリングが必要であり、LFIAベースの迅速検査は迅速な結果を提供し、慢性疾患の管理に役立ちます。世界保健機関は、非感染性疾患（NCD）が原因と考えられるかなりの数の死亡を毎年報告しており、心血管疾患、がん、慢性呼吸器疾患、糖尿病などの疾患への対処におけるLFIAの役割を強調しています。したがって、市場は慢性疾患の発生率の上昇によって刺激されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場、技術別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コンペティティブアッセイ
  • サンドイッチアッセイ
  • 多重検出アッセイ
  • 世界のラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 感染症
  • 妊娠と妊孕性
  • 毒物学
  • その他の用途
  • 世界のラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院とクリニック
  • 診断検査室
  • 在宅ケア
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場の競合情勢
  • ラテラルフローイムノアッセイ（LFIA）ベース迅速検査市場の企業プロファイル
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

第31章 その他の大手および革新的な企業

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO Biotechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio Biotechnology Systems
  • Elabscience（R）Immunoassay Kits
  • FyoniBio/Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14499

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has declined steeply in recent years. It will grow from ' $9.19 billion in 2023 to $8.33 billion in 2024 at a compound annual growth rate (CAGR) of -9.4%. The growth observed in the historical period can be ascribed to several factors, including a surge in infectious disease cases, heightened demand for point-of-care testing within home care settings, augmented healthcare expenditure, and the expansion of emerging markets.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see marginal decline in the next few years. It will grow to $7.79 billion in 2028 at a compound annual growth rate (CAGR) of -1.6%. The growth anticipated in the forecast period can be attributed to several factors, including increased healthcare access, the impact of the COVID-19 pandemic, a rising aging population, a growing demand for home-based lateral flow assay devices, enhanced accessibility, and an upswing in regulatory approvals. Noteworthy trends in the forecast period involve the advancement of technologies for multiple or repetitive LFIA-based rapid tests and the storage/communication of results. There is also a focus on forming partnerships and collaborations to introduce new or improved products, the development of at-home test kits for patients to self-administer and manage their health in their own homes, investments in artificial intelligence-based tests for disease screening and detection, and the imperative to create low-cost test kits to ensure affordable access for patients.

The lateral flow immunoassay (LFIA) based rapid test market is anticipated to witness growth driven by the demand for point-of-care testing in home care settings. Point-of-care testing is crucial for swift on-site diagnosis and treatment, with LFIA being widely used due to its speed, precision, simplicity, and cost-effectiveness. The recent COVID-19 outbreak has underscored the significance of LFIA devices for rapid screening and surveillance, as seen with products such as Acro Biotech COVID-19 Rapid POC CE-IVD and OZO's variations employing Latex Enhanced Lateral Flow Immunoassays (LFIAs) for COVID-19 testing. Consequently, the market is expected to thrive due to the need for point-of-care testing in home care settings.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Leading companies in the lateral flow immunoassay (LFIA) based rapid test market are concentrating on innovative products to enhance their market share. Notable among these is Abbott Laboratories, which introduced the Panbio COVID-19 antigen self-test, designed for individuals to self-detect the SARS-CoV-2 virus causing COVID-19. The self-test employs Abbott's lateral flow technology, providing quick results within 15 minutes using a minimally invasive nose swab. To streamline the process, Abbott's NAVICA mobile app facilitates self-registration, result interpretation, and reporting in accordance with ICMR requirements.

The focus on healthcare investments by various stakeholders is intensifying, contributing to the lateral flow immunoassay (LFIA) based rapid test market. Such investments support research and development efforts aimed at improving LFIA test sensitivity, specificity, and overall performance. This includes the development of new LFIA assays, identification of novel biomarkers, and enhancements in detection methods. In Australia, the government has substantially increased hospital funding, reaching an estimated $32.7 billion in 2025-26, showcasing a commitment to healthcare investments.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (lfia) based rapid test market report are Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience® Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd., Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., CTK Biotech, Wamadiagnostica, Marksans Pharma Ltd., Lana Al Khaleej, Natejah Medical Supplies, Synlab, K2 Medical's, SA Biomedical Group

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2023. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (lfia) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (lfia) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
  • 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
  • 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End Users
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size and Growth

  • 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Competitive Assay
  • Sandwich Assay
  • Multiplex Detection Assay
  • 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Disease
  • Pregnancy & Fertility
  • Toxicology
  • Other Applications
  • 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Other End Users

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
  • 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Quidel Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • 31.1. Siemens AG
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Hologic, Inc.
  • 31.6. LTEK Co., Ltd.
  • 31.7. JOYSBIO Biotechnology
  • 31.8. Jiangsu Medomics Medical Technologies
  • 31.9. Diagnocure
  • 31.10. Ubio Biotechnology Systems
  • 31.11. Elabscience® Immunoassay Kits
  • 31.12. FyoniBio / Glycotope GmbH
  • 31.13. Atomo Diagnostics Limited
  • 31.14. INDICAL Bioscience
  • 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking

33. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Future Outlook and Potential Analysis

  • 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer